In addition, blockade of GM-CSF derived from PDAC by either a GM-CSF-neutralizing antibody or a specific knockdown of GM-CSF in pancreatic cancer cells suppressed tumor growth with less infiltrating Gr-1+CD11b+ cells in vivo. The gene discussed is CSF2; the disease is pancreatic neoplasm.